Discontinued — last reported Q3 '24
MetLife RIS — Benefits, Losses and Expenses decreased by 25.4% to $3.12B in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 19.8%, from $3.89B to $3.12B. Over 2 years (FY 2021 to FY 2023), RIS — Benefits, Losses and Expenses shows an upward trend with a 25.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to premiums earned indicates improved underwriting margins and operational efficiency, while an increase suggests rising claims or higher costs.
Aggregates all costs associated with policyholder benefits, claims incurred, settlement expenses, and operating costs sp...
Equivalent to 'Total Benefits and Expenses' or 'Underwriting and Operating Expenses' reported by life insurance segments.
met_segment_ris_benefits_losses_and_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.31B | $2.31B | $2.31B | $4.62B | $4.62B | $4.62B | $4.62B | $1.96B | $4.24B | $3.89B | $4.38B | $2.40B | $4.18B | $3.12B |
| QoQ Change | — | +0.0% | +0.0% | +99.5% | +0.0% | +0.0% | +0.0% | -57.6% | +116.9% | -8.3% | +12.6% | -45.3% | +74.4% | -25.4% |
| YoY Change | — | — | — | — | +99.5% | +99.5% | +99.5% | -57.6% | -8.0% | -15.6% | -5.0% | +22.5% | -1.5% | -19.8% |